Sort
261,768 grants matching “gene therapy”
Targeted Therapies in Melanoma
$2,567,345Meenhard Herlyn · Wistar Institute · P01 · FY2013 · CA
Gene Transfer And Ex Vivo Manipulation Of Hematopoietic Cells
$2,566,909Cynthia E Dunbar · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
Clinical Evaluation of PET Radiotracers
$2,566,871Robert Innis · National Institute Of Mental Health · ZIA · FY2023 · MH
BIODISTRIBUTION AND TOXICOLOGY ASSESSMENT OF GENE THERAPY FOR POST-OPERATIVE ATRIAL FIBRILLATION
$2,566,849University Of Massachusetts Medical School · · FY2016 · Department of the Army
Essential gene discovery in the malaria parasite Plasmodium falciparum
$2,566,672Jeffrey D Dvorin · Boston Children'S Hospital · DP2 · FY2013 · AI
Basal Ganglia in Health and Disease
$2,566,670Guohong Cui · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
Metabolic determinants of Mtb virulence, vulnerability and variation
$2,566,475David Branch Moody · Brigham And Women'S Hospital · U19 · FY2023 · AI
Mouse models of stress disorders and addiction
$2,565,800Andrew Holmes · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2021 · AA
Determinants of TB control, relapse and reinfection
$2,565,026Sabine Ehrt · Weill Medical Coll Of Cornell Univ · U19 · FY2023 · AI
THE UW/FHCRC PROGRAM OF EXCELLENCE IN GENE THERAPY
$2,565,002University Of Washington · U01 · FY2000 · HL
A Human Stem Cell-Derived Neuromuscular Junction Model for Amyotrophic Lateral Sclerosis
$2,565,000Brian Jason Wainger · Massachusetts General Hospital · DP2 · FY2017 · NS
Defining and Exploiting a Genetic Template for an HIV Vaccine
$2,565,000Daniel Lingwood · Massachusetts General Hospital · DP2 · FY2016 · DA
Defining Melanoma Therapeutic Avenues by Integrative Functional Genomics
$2,565,000Levi Alexander Garraway · Dana-Farber Cancer Inst · DP2 · FY2007 · OD
Molecular Targeting of Developmental Cancers in Children
$2,564,487Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2007 · CA
Mechanisms and Therapy of Chronic Graft-vs.-Host Disease
$2,563,941Corey S Cutler · Dana-Farber Cancer Inst · P01 · FY2025 · HL
Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors (SOARS-B)
$2,562,872Linmarie Sikich · Univ Of North Carolina Chapel Hill · U01 · FY2014 · HD
Development Of New Approaches To Vaccines Against TBEV and West Nile Virus
$2,562,752Alexander Pletnev · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Genetic Modifiers of Cancer Risk
$2,562,510Lisa Mirabello · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA
Functional Magnetic Resonance Imaging Of Emotion As Related To Alcoholism
$2,562,361Markus Heilig · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2014 · AA
Protection of Ischemic Myocardium
$2,562,122Roberto Bolli · University Of Louisville · P01 · FY2012 · HL
Genome Characterization Center (GCC)
$2,562,032Matthew L Meyerson · Broad Institute, Inc. · U24 · FY2012 · CA
University of Texas PDX Development and Trial Center
$2,561,686Jack Roth · University Of Tx Md Anderson Can Ctr · U54 · FY2017 · CA
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$2,561,153Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Molecular epidemiology of acute lymphoblastic leukemia in children with Down syndrome
$2,561,043Karen R Rabin · Baylor College Of Medicine · R01 · FY2020 · CA
Sleeping Beauty Engineered B Cells for Mucopolysaccharidosis
$2,560,312Christiane S Hampe · Immusoft Corporation · R44 · FY2019 · GM